Cargando…
Vedolizumab for perianal fistulizing Crohn’s disease: systematic review and meta-analysis
BACKGROUND/AIMS: Perianal fistulas are a debilitating manifestation of Crohn’s disease (CD). Despite the advent of anti-tumor necrosis factor (anti-TNF) therapy, the medical management of fistulizing CD continues to be challenged by unmet needs. We conducted a systematic review and meta-analysis of...
Autores principales: | Ayoub, Fares, Odenwald, Matthew, Micic, Dejan, Dalal, Sushila R., Pekow, Joel, Cohen, Russell D., Rubin, David T., Sakuraba, Atsushi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Association for the Study of Intestinal Diseases
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081994/ https://www.ncbi.nlm.nih.gov/pubmed/35124951 http://dx.doi.org/10.5217/ir.2021.00091 |
Ejemplares similares
-
A Clinical Predictive Model for One-year Colectomy in Adults Hospitalized for Severe Ulcerative Colitis
por: Zafer, Maryam, et al.
Publicado: (2021) -
Adenocarcinoma Arising from Perianal Fistulizing Crohn's Disease
por: Fornaro, Rosario, et al.
Publicado: (2018) -
Therapeutic Drug Monitoring in Perianal Fistulizing Crohn’s Disease
por: Zulqarnain, Mir, et al.
Publicado: (2022) -
Factors associated with readmission to the hospital within 30 days in patients with inflammatory bowel disease
por: Micic, Dejan, et al.
Publicado: (2017) -
Optimized timing of using infliximab in perianal fistulizing Crohn's disease
por: Sun, Xue-Liang, et al.
Publicado: (2020)